Author(s):
Siddhant M. Sawant, Prashant J. Burange, Maithili P. Amale, Pankaj H. Chaudhary, Adnya D. Bahurupi
Email(s):
prashantburange@gmail.com
DOI:
10.52711/2231-5675.2024.00043 
Address:
Siddhant M. Sawant, Prashant J. Burange*, Maithili P. Amale, Pankaj H. Chaudhary, Adnya D. Bahurupi
Department of Pharmaceutical Quality Assurance, P. R. Pote Patil College of Pharmacy, Sant Gadge Baba Amravati University, Amravati 444602, Maharashtra, India.
*Corresponding Author
Published In:
Volume - 14,
Issue - 4,
Year - 2024
ABSTRACT:
In this study, we developed and validated a rapid and precise RP-HPLC method to quantify leflunomide in bulk and tablet dosage forms. The analysis was performed using an Inertsil-ODS C18 column (250x4.6mm, 5µm) with a mobile phase composed of 95:5 methanol/water at a flow rate of 1mL/min. Leflunomide demonstrated a linear range between 20-70µg/ml with a high correlation coefficient (R² = 0.995). Adhering to ICH guidelines, the method was designed to be accurate, precise, sensitive, selective, repeatable, and robust. The validation parameters included system suitability, specificity, linearity, accuracy, precision, detection limit, quantitation limit, robustness, and stability. The results indicated excellent accuracy and precision, with recoveries close to 100% and relative standard deviations well within acceptable limits. The method's sensitivity allowed for reliable detection and quantification at low concentrations, making it ideal for routine quality control. Additionally, robustness studies confirmed the method's reliability despite minor changes in experimental conditions. This HPLC method is both efficient and cost-effective, enabling faster analysis while maintaining high quality. The validated method was successfully applied to the analysis of leflunomide in pharmaceutical formulations, proving its suitability for routine use in quality control laboratories. Overall, this method offers a comprehensive solution for accurately estimating leflunomide in various dosage forms.
Cite this article:
Siddhant M. Sawant, Prashant J. Burange, Maithili P. Amale, Pankaj H. Chaudhary, Adnya D. Bahurupi. Siddhant M. Sawant, Prashant J. Burange, Maithili P. Amale, Pankaj H. Chaudhary, Adnya D. Bahurupi. Asian Journal of Pharmaceutical Analysis. 2024; 14(4):241-6. doi: 10.52711/2231-5675.2024.00043
Cite(Electronic):
Siddhant M. Sawant, Prashant J. Burange, Maithili P. Amale, Pankaj H. Chaudhary, Adnya D. Bahurupi. Siddhant M. Sawant, Prashant J. Burange, Maithili P. Amale, Pankaj H. Chaudhary, Adnya D. Bahurupi. Asian Journal of Pharmaceutical Analysis. 2024; 14(4):241-6. doi: 10.52711/2231-5675.2024.00043 Available on: https://ajpaonline.com/AbstractView.aspx?PID=2024-14-4-7
REFERENCES:
1. Srinivas RV, Narasimha RM, Allam AR, Maheswari I, Srinubabu G. Development and validation of LC method for the determination of leflunomide in pharmaceutical formulations using an experimental design. Afr J Pure Appl Chem. 2008; 2(2):10-7.
2. Adhao Vaibhav S., Ambhore Jaya P., Thenge Raju R. Development and Validation of Stability Indicating High Performance Liquid Chromatography Method for Determination of Leflunomide. Asian Journal of Pharmaceutical Analysis. 2023; 13(2): 93-8. doi: 10.52711/2231-5675.2023.00016
3. Rastogi RP, Mehrotra BN. Compendium of Indian medicinal plants. Vol. 2. Lucknow and New Delhi: Central Drug Research Institute and National Institute of Science Communication; 1980. p. 473-5.
4. Schiff MH, Whelton A. Renal toxicity associated with disease-modifying antirheumatic drugs used for the treatment of rheumatoid arthritis. Semin Arthritis Rheum. 2000; 30(3): 196-208. doi: 10.1053/sarh.2000.16641. PMID: 11124283.
5. Herrmann ML, Schleyerbach R, Kirschbaum BJ. Leflunomide: an immunomodulatory drug for the treatment of rheumatoid arthritis and other autoimmune diseases. Immunopharmacology. 2000; 47(2-3): 273-89. doi: 10.1016/s0162-3109(00)00191-0. PMID: 10878294.
6. Viviano KR. Pharmacotherapeutics of immune-mediated disease. Pharmacother Vet Dispensing. 2019: 3: 39-60.
7. Gupta S, George M, Singhal M, Sharma GN, Garg V. Leaves extract of Murrayakoenigii Linn for anti-inflammatory and analgesic activity in animal models. J Adv Pharm Technol Res. 2010; 1(1): 68-77. PMID: 22247833.
8. Stomrud E, Bjorkqvist M, Janciauskiene S, Minthon L, Hansson O. Alterations of matrix metalloproteinases in the healthy elderly with increased risk of prodromal Alzheimer’s disease. Alzheimers Res Ther. 2010; 2(3): 20. doi: 10.1186/alzrt44. PMID: 20576109.
9. Nussbaumer S, Bonnabry P, Veuthey JL, FleurySouverain S. Analysis of anticancer drugs: a review. Talanta. 2011;85(5):2265-89. doi: 10.1016/j.talanta.2011.08.034. PMID: 21962644.
10. Srinubabu G, Raju Ch A, Sarath N, Kumar PK, Rao JV. Development and validation of a HPLC method for the determination of voriconazole in pharmaceutical formulation using an experimental design. Talanta. 2007; 71(3): 1424-9. doi: 10.1016/j.talanta.2006.04.042. PMID: 19071468.
11. Md. Ahsanul Haque, Mohammad Shahriar, Most. Nazma Parvin, S. M. Ashraful Islam. Validated RP-HPLC Method for Estimation of Ranitidine Hydrochloride, Domperidone and Naproxen in Solid Dosage Form.Asian J. Pharm. Ana. 2011; 1(3): 59-63.
12. Akhilesh Gupta, Swati Rawat, Mayuri Gandhi, Jaydeep Singh Yadav. Method Development and Acid Degradation Study of Doxofylline by RP-HPLC and LC-MS/MS. Asian J. Pharm. Ana. 2011; 1(1): 10-13.
13. L. Satyanarayana, S.V. Naidu, M. Narasimha Rao, C. Ayyanna, Alok Kumar. The Estimation of Raltigravir in Tablet dosage form by RP-HPLC. Asian J. Pharm. Ana. 2011; 1(3): 56-58.
14. B. Thangabalan, M. Salomi, N. Sunitha, S. ManoharBabu. Development of validated RP-HPLC method for the estimation of Itraconazole in pure and pharmaceutical dosage form. Asian J. Pharm. Ana. 2013; 3(4): 119-123.